SULLI, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 1.349
EU - Europa 312
AS - Asia 206
SA - Sud America 8
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.881
Nazione #
US - Stati Uniti d'America 1.339
SG - Singapore 88
IT - Italia 79
UA - Ucraina 77
IN - India 73
CN - Cina 44
FI - Finlandia 42
SE - Svezia 36
IE - Irlanda 32
DE - Germania 20
AR - Argentina 8
CA - Canada 7
GB - Regno Unito 6
BE - Belgio 5
NL - Olanda 4
MX - Messico 3
CH - Svizzera 2
FR - Francia 2
RO - Romania 2
RS - Serbia 2
TG - Togo 2
ZA - Sudafrica 2
AU - Australia 1
BG - Bulgaria 1
DK - Danimarca 1
EU - Europa 1
IR - Iran 1
RU - Federazione Russa 1
Totale 1.881
Città #
Fairfield 223
Chandler 129
Seattle 96
Houston 94
Ashburn 90
Cambridge 84
Woodbridge 84
Wilmington 79
Singapore 56
Ann Arbor 55
Princeton 54
Plano 38
San Paolo di Civitate 37
Beijing 36
Dublin 32
Millbury 29
Rome 28
Lawrence 26
Jacksonville 25
Des Moines 15
San Diego 15
Boston 10
Dearborn 10
Andover 9
Federal 8
Brussels 5
Santa Clara 5
Fremont 4
Helsinki 4
New York 4
Norwalk 4
Ottawa 4
Bühl 3
Toronto 3
Bern 2
Boardman 2
Dallas 2
Laurel 2
Lomé 2
Muizenberg 2
Scurcola Marsicana 2
Southend 2
Arnsberg 1
Belgrade 1
Berlin 1
Bremen 1
Clyde North 1
Den Haag 1
Falls Church 1
Fort Worth 1
Frederiksberg 1
Gruissan 1
Indiana 1
Kragujevac 1
Kunming 1
London 1
Lucca 1
Marseille 1
Miami 1
Milan 1
Nanchang 1
Nanjing 1
Ningbo 1
Provo 1
Sacramento 1
San Pablo 1
Sofia 1
Springfield 1
Wuhan 1
Xian 1
Totale 1.442
Nome #
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI). 95
Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes. 80
Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment. 74
Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: Three case reports 68
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study) 67
Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. 63
A male patient with 48,XXYY syndrome: importance of distinction from Klinefelter's syndrome. 63
Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: Evidence from a nationwide Italian twin study 62
Use of Integrated Real-Time Continuous Glucose Monitoring/Insulin Pump System in Children and Adolescents with Type 1 Diabetes: A 3-Year Follow-Up Study 61
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial 61
Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis 60
Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study 60
Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study 60
GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva 59
Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII) 59
The SWITCH study (sensing with insulin pump therapy to control HbA 1c): Design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy 54
ALTERAZIONI DELL’OMEOSTASI GLUCIDICA: DIABETE MELLITO 53
Variable number of tandem repeats in zygosity diagnosis in twins. 51
Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males? 49
Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up 48
Permanent diabetes during the first year of life: Multiple gene screening in 54 patients 46
Maturity-Onset Diabetes of the Young in Children With Incidental Hyperglycemia: A multicenter Italian study of 172 families 46
LE SPORT, UNE ARME ESSENTIELLE DANS LA LUTTE CONTRE LE DIABETE, 45
Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol 45
La retinopatia diabetica 37
Il mio microinfusore. guida all'uso del microinfusore 37
GAD and IA-2 immunoreactivity in type 1 diabetic patient saliva 37
High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetes (SIEDP). 37
CFRD and IGT in patients with CF: a single centre experience 34
CONTINOUS SUBCUTANEOUS INSULIN INFUSION (CSII) IN ITALY 33
Insulin pump therapy in children and adolescents with type 1 diabetes: The Italian viewpoint 33
RISK FOR THE DEVELOPMENT OF TYPE I DIABETES IN CHILDREN WITH INCIDENTAL HYPERGLYCEMIA (MULTICENTER ITALIAN STUDY) DIABETES CARE 32
Iperglicemie occasionali del bambino 29
[Review of the Pena-Shokeir syndrome I, Pena-Shokeir II and Neu-Laxova. Clinical and interpretative contribution]. 28
MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of "neonatal diabetes"? 26
Insulin secretion at diagnosis of type 1 diabetes is associated with both age of onset and HLA class II 25
RACCOMANDAZIONI ITALIANE ALL’UTILIZZO DEL MICROINFUSORE IN ETÀ PEDIATRICA. 24
Guideline. Oral health for people with diabetes 23
Multicentric approach to the Steinert's myotonic dystrophy 21
null 11
The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: An Italian multicentre survey* 9
Totale 1.905
Categoria #
all - tutte 5.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.342


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020364 0 0 4 24 42 55 46 55 50 37 38 13
2020/2021164 29 21 15 10 1 23 3 12 15 14 14 7
2021/2022366 0 26 34 12 55 4 8 44 29 32 38 84
2022/2023421 100 81 24 23 45 49 10 14 58 10 7 0
2023/2024120 11 29 1 14 6 7 1 7 0 19 9 16
2024/202564 25 20 19 0 0 0 0 0 0 0 0 0
Totale 1.905